| | |
| Clinical data | |
|---|---|
| Routes of administration | Oral |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.017.021 |
| Chemical and physical data | |
| Formula | C7H14Cl3NO4 |
| Molar mass | 282.54 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Chloral betaine (USAN, BAN) (brand names Beta-Chlor, Somilan), also known as cloral betaine (INN), is a sedative-hypnotic drug. [1] [2] [3] [4] It was introduced by Mead Johnson in the United States in 1963. [5] It is a betaine complex of trimethylglycine with chloral hydrate, which acts as an extended-acting formulation of chloral hydrate which is then metabolized into trichloroethanol, which is responsible for most or all of its effects. [3] [4] [6]